EOM Pharmaceuticals
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Proof-of-Concept Study Evaluating EOM613 in COVID-19 Infected Patients With Severe Symptoms (NCT05212532) | EOM Pharmaceuticals | 2021-08-09 |
Track EOM Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.